![]() |
![]() |
(5α,17β)-17-(Acetyloxy)-1-methylandrost-1-en-3-one 17-(acetyloxy)-1-methyl-,(5-alpha,17-beta)-androst-1-en-3-on 17-beta-hydroxy-1-methyl-5-alpha-androst-1-en-3-onacetate 17-beta-hydroxy-1-methyl-5-alpha-androst-1-en-3-oneacetate 17b-Hydroxy-1-methyl-5a-androst-1-en-3-one acetate 17β-Hydroxy-1-methyl-5α-androst-1-en-3-one acetate 1-Methyl-17b-hydroxy-5a-androst-1-en-3-one acetate 1-Methyl-17β-hydroxy-5α-androst-1-en-3-one acetate 1-Methyl-17β-hydroxy-5α-androst-1-en-3-one-17β-acetate 1-Methyl-5α-androst-1-en-17β-ol-3-one acetate 5α-Androst-1-en-3-one, 17β-hydroxy-1-methyl-, acetate Androst-1-en-3-one, 17-(acetyloxy)-1-methyl-, (5α,17β)- METENOLONE ACETATE Methenolone 17-acetate METHENOLONE ACETATE nibal NSC 74226 Primobolan Primobolan Tablets Primobolone Primonabol SH 567 SH 567a SQ 16496
The Methenolone acetate has the cas register number 434-05-9, and it has the systematic name of (5alpha)-1-methyl-3-oxoandrost-1-en-17-yl acetate. This chemical is a kind of white or almost white crystalline powder. Besides, its product categories are including steroids.
The characteristics of this chemical are as follows: (1)ACD/LogP: 4.93; (2)ACD/LogD (pH 5.5): 4.92; (3)ACD/LogD (pH 7.4): 4.92; (4)ACD/BCF (pH 5.5): 3258.08; (5)ACD/BCF (pH 7.4): 3258.08; (6)ACD/KOC (pH 5.5): 11380.8; (7)ACD/KOC (pH 7.4): 11380.8; (8)#H bond acceptors: 3; (9)#Freely Rotating Bonds: 2; (10)Polar Surface Area: 43.37; (11)Index of Refraction: 1.536; (12)Molar Refractivity: 97.3 cm3; (13)Molar Volume: 311.8 cm3; (14)Polarizability: 38.57×10-24 cm3; (15)Surface Tension: 41.2 dyne/cm; (16)Density: 1.1 g/cm3; (17)Flash Point: 189.9 °C; (18)Enthalpy of Vaporization: 69.85 kJ/mol; (19)Boiling Point: 441.2 °C at 760 mmHg; (20)Vapour Pressure: 5.54E-08 mmHg at 25°C; (21)Exact Mass: 344.235145; (22)MonoIsotopic Mass: 344.235145; (23)Topological Polar Surface Area: 43.4; (24)Heavy Atom Count: 25; (25)Complexity: 635.
In addition, you could obtain the molecular structure by converting the following datas:
(1)SMILES:CC(=O)OC1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)\C=C(\C)[C@]4(C)[C@H]3CC[C@]12CCopyCopied
(2)InChI:InChI=1/C22H32O3/c1-13-11-16(24)12-15-5-6-17-18-7-8-20(25-14(2)23)21(18,3)10-9-19(17)22(13,15)4/h11,15,17-20H,5-10,12H2,1-4H3/t15-,17-,18-,19-,20?,21-,22-/m0/s1
Below are the toxicity information of this chemical:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | > 2gm/kg (2000mg/kg) | ? | Drugs in Japan Vol. -, Pg. 1370, 1995. |
mouse | LD50 | oral | > 4gm/kg (4000mg/kg) | ? | Drugs in Japan Vol. -, Pg. 1370, 1995. |
rat | LD50 | oral | > 4gm/kg (4000mg/kg) | ? | Drugs in Japan Vol. -, Pg. 1370, 1995. |
Acute toxicity - Oral, Category 4
Carcinogenicity, Category 2
Reproductive toxicity, Category 1A
Reproductive toxicity, Additional category for effects on or via lactation
Pictogram(s) | ![]() ![]() |
---|---|
Signal word | Danger |
Hazard statement(s) | H302 Harmful if swallowed H351 Suspected of causing cancer H360 May damage fertility or the unborn child H362 May cause harm to breast-fed children |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/protective clothing/eye protection/face protection. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P263 Avoid contact during pregnancy and while nursing. |
Response | P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/\u2026if you feel unwell. P330 Rinse mouth. P308+P313 IF exposed or concerned: Get medical advice/ attention. |
Storage | P405 Store locked up. |
Disposal | P501 Dispose of contents/container to ... |
none
![]() |
Literatures:
Torrini; Romeo Farmaco, Edizione Scientifica, 1980 , vol. 35, # 8 p. 681 - 683 ![]() Yield: ~8% |